Yasmin, 2022 (2) Balochitsan
Yasmin, 2022 (2) Balochitsan
Yasmin, 2022 (2) Balochitsan
Background and Objectives: During the pandemic, the growing influence of social
Edited by: media, accessibility of over-the-counter medications, and fear of contracting the virus
Chantal M. Morel, may have led to self-medication practices among the general public. Medical students
Université de Genève, Switzerland
are prone to such practices due to relevant background knowledge, and access to drugs.
Reviewed by:
Hashaam Akhtar,
This study was carried out to determine and analyze the prevalence of self-medication
Yusra Institute of Pharmaceutical practices among medical students in Pakistan.
Sciences Islamabad, Pakistan
Sarosh Iqbal, Materials and Methods: This descriptive, cross-sectional study was conducted
University of the Punjab, Pakistan online in which the participants were asked about the general demographics, their self-
Ali Hassan Gillani,
Xi’an Jiaotong University, China
medication practices and the reasons to use. All participants were currently enrolled
Amal Akour, in a medical college pursuing medical or pharmacy degree. Non-probability sampling
The University of Jordan, Jordan technique was used to recruit participants.
*Correspondence:
Muhammad Sohaib Asghar Results: A total of 489 respondents were included in the final analysis. The response
[email protected] rate was 61%. Majority of the respondents were females and 18–20 years of age. Self-
medication was quite prevalent in our study population with 406 out of 489 individuals
Specialty section:
This article was submitted to
(83.0%) were using any of the drugs since the start of pandemic. The most commonly
Infectious Diseases – Surveillance, utilized medications were Paracetamol (65.2%) and multivitamins (56.0%). The reasons
Prevention and Treatment,
reported for usage of these medications included cold/flu, or preventive measures
a section of the journal
Frontiers in Public Health for COVID-19. The common symptoms reported for self-medication included fever
Received: 28 October 2021 (67.9%), muscle pain (54.0%), fatigue (51.7%), sore throat (46.6%), and cough (44.4%).
Accepted: 07 February 2022 Paracetamol was the most commonly used drug for all symptoms. Female gender, being
Published: 09 March 2022
in 3rd year of medical studies, and individuals with good self-reported health were found
Citation:
Yasmin F, Asghar MS, Naeem U,
more frequent users of self-medication practices.
Najeeb H, Nauman H, Ahsan MN and Conclusion: Our study revealed common self-medication practices among medical
Khattak AK (2022) Self-Medication
Practices in Medical Students During and pharmacy students. It is a significant health issue especially during the pandemic
the COVID-19 Pandemic: A times, with high consumption reported as a prevention or treating symptoms
Cross-Sectional Analysis.
of COVID-19.
Front. Public Health 10:803937.
doi: 10.3389/fpubh.2022.803937 Keywords: self-medication, medical students, COVID-19, pandemic, public health, Pakistan
drugs listed in the survey included acetaminophen, ibuprofen, region, presence of comorbid conditions, and self-reported
azithromycin, hydroxychloroquine, ivermectin, doxycycline, health as control variables. Categorical variables were assessed
antivirals (lopinavir, ritonavir, remdesivir, and others), cetirizine, using frequencies and percentages, through univariate analysis.
multivitamin compounds or any other drug (open question) for Analytical statistics were performed with 95% confidence
respiratory symptoms. All drugs were classified according to the intervals (CI) and odds ratios (OR), which were obtained using
Anatomical Therapeutic Chemical (ATC) (18). This selection logistic regression.
of drugs was based on the existing literature, and reports
from the local media. COVID-19 can present with a range
of symptoms. Frequently reported symptoms were obtained RESULTS
from CDC’s guidelines (19). The list of symptoms included
fever, fatigue, cough, muscle ache, nasal congestion, sore throat, A total of 374 medical and 115 pharmacy students were included
headache, breathing difficulty, no symptom, and other symptom in the final analysis. The response rate was 61%. Majority of the
(open question). Anosmia was omitted as being controversial at respondents were of 18–20 years of age (58.5%). More than three-
the time of inception of this study (16). To assess the reason for fourths were females. 34.0% of medical students were in first year,
drug use, participants had seven options listed as cold/flu, no 20.6% in second year, 20.3% in third year, 13.9% in fourth year,
symptoms, COVID-19 prevention, had COVID-19 symptoms, and 11.2% were in final year of their medical education. Most
COVID-19 positive, consume the drug regularly, other reason respondents were from province Sindh and Punjab (combined
(open question). The following 5-point Likert scale was used to 85.7%). Only 4.5% reported previous comorbid conditions, while
identify and list the improvement in symptoms if any: improved majority (60.5%) were in good state of self-reported health. While
all symptoms, improved most of the symptoms, improved a few reporting the risk of acquiring COVID-19 infection, 43.8% were
of the symptoms, improved only one symptom, did not alleviate unbothered. Another 38.0% admitted mild risk while only 2.9%
any of the symptoms. reported severe risk. 15.3% of participants were already infected
with the virus. The socio-demographic characteristics of the
Sample Size/Sampling Technique participants are described in Table 1.
The sample size of the survey was obtained from the pilot study Self-medication was prevalent in our study population with
determined using the power analysis. The minimum sample size 316 out of 374 medical students (84.5%) and 90 out of 115
was 385, with a statistical power of 80% and a confidence interval pharmacy students (78.3%) were using any of the drugs since the
of 95%. We hypothesized that at least 50% of the participants start of pandemic. The most commonly utilized medications were
would practice self-medication, with a 5% margin of error. Paracetamol (65.2%), multivitamins (56.0%), Ibuprofen (29.0%),
The formula for sample size estimation was n = N ×/((N- Cetirizine (27.8%), and Azithromycin (25.6%) among others.
1) E2 + x), where N is the population size and n is sample The reasons reported for usage of these medications included
size estimation. A non-probability sampling technique was used cold/flu (71.4%), as preventive measures for COVID-19 (43.3%),
to recruit participants from social media platforms, including or a self-medication for COVID-19 symptoms (34.1%). However,
WhatsApp, Facebook, and Messenger. 35.2% reported taking these medications without any reason
or symptoms, while another 40.1% consumed them regularly
Inclusion/Exclusion Criteria for other reasons. The symptoms reported for self-medication
Inclusion criteria included completed responses, and the included fever (67.9%), fatigue (51.7%), cough (44.4%), sneezing
respondent i.e., male or a female medical student pursuing MBBS (40.7%), muscle pain/body aches (54.0%), nasal congestion
or Pharm D degree from a medical college in Pakistan, having (42.1%), sore throat (46.6%) anosmia (23.1%), and breathing
the ability to understand English, and being technologically adept difficulty (24.5%) as shown in Table 1. Paracetamol was the most
and have access to Internet. While exclusion criteria included commonly used drug for all symptoms including fever, fatigue,
respondents from other than the medical field. cough, sneezing, myalgia, nasal congestion, sore throat, anosmia,
and shortness of breath. Figure 1 demonstrates the relative
Ethical Approval proportions of drug use for each specific symptomatology.
The study received ethical approval from the Institution’s Paracetamol use was common in individuals >21 years,
Ethics Committee of the Dow University Ojha Hospital. Each final year medical students, those already infected with
participant had the right to withdraw from the study at any time. COVID-19, and having flu, fever, and fatigue. 45.4% shown
The possible risks and the purpose of the survey were thoroughly all or most symptoms resolved with its use as shown
explained. Participants had to provide consent before filling out in Table 2. Azithromycin use was common in age >21
the questionnaire. years, 5th year medical students, inhabitants of Khyber
Pakhtunkhwa/Balochistan, as well as those already infected
Data Analysis with COVID-19. Cetirizine use was frequent among pharmacy
Microsoft Excel 2016 was used for data collection and assembled students, final year medical students and those with self-reported
in to Statistical Package for Social Sciences (SPSS) version 25.0 risk of COVID-19 infection. Use of antivirals was prevalent
for data analysis. A multivariate analysis estimated the preference among males of above 21 years of age. Use of multivitamins
of self-medication for the surveyed drugs using the baseline was also common in individuals >21 years, females, residents
demographics i.e., sex, age, marital status, educational status, of Khyber Pakhtunkhwa/Balochistan and those either already
2020 review, however, among affected countries, Pakistan had is the first of its kind within the current pool of literature
one of the highest prevalence of 81.23%, with only 7.3% in available, that has evaluated self-medication among medical
Indonesia and 26.9% in Bangladesh (21). A study conducted by students in the context of COVID-19, encompassing most
the Aga Khan University, Karachi in 2008 revealed 76% self- provinces of Pakistan.
medication rates among the medical and non-medical university The incidence of self-medication revealed in our results is
students surveyed (22), while another survey from pre-COVID around 83%, a finding that is comparable to self-medication
times, consisting of a small segment of medical students in occurrence rates during COVID-19 reported in studies
Pakistan found 99% of them to be engaged in practicing conducted abroad. Among the nursing undergraduates in Saudi
self-medication (23). To the best of our knowledge, our study Arabia, self-medication practice with antibiotics and analgesics
Yasmin et al.
TABLE 2 | Factors associated with self-medication of various drugs among medical students during the COVID-19 lockdown (n = 489).
Factor Parace-tamol Ibuprofen Azithro-mycin HCQ Iver-mectin Doxy- Cetirizine N Antiviral Multi-vitamin Other
N = 319 N = 142 N = 125 N = 43 N = 22 cycline = 136 N = 35 N = 274 N = 56
N = 19
Age (years)
18–20 155 (48.6) 76 (53.5) 50 (40.0) 26 (60.4) 11 (50.0) 12 (63.2) 65 (47.8) 12 (34.3) 140 (51.1) 32 (57.1)
21–25 and above 164 (51.4) 66 (46.5) 75 (60.0) 17 (39.5) 11 (50.0) 7 (36.8) 71 (52.2) 23 (65.7) 134 (48.9) 24 (42.9)
Gender
Female 251 (78.7) 114 (80.3) 92 (73.6) 34 (79.1) 18 (81.8) 11 (57.9) 100 (73.5) 20 (57.1) 233 (85.0) 43 (76.8)
Male 68 (21.3) 28 (19.7) 33 (26.4) 9 (20.9) 4 (18.2) 8 (42.1) 36 (26.5) 15 (42.9) 41 (15.0) 13 (23.2)
Student
Medical 244 (76.5) 109 (76.8) 95 (76.0) 34 (79.1) 17 (77.3) 15 (78.9) 95 (69.8) 27 (77.1) 209 (76.3) 44 (78.6)
Pharmacy 75 (23.5) 33 (23.2) 30 (24.0) 9 (20.9) 5 (22.7) 4 (21.1) 41 (30.1) 8 (22.9) 65 (23.7) 12 (21.4)
Medical year
1st year 65 (26.6) 28 (25.7) 24 (25.3) 15 (44.1) 5 (29.4) 3 (20.0) 21 (21.6) 6 (22.2) 69 (33.0) 19 (43.2)
2nd year 49 (20.1) 22 (20.2) 15 (15.8) 6 (17.6) 2 (11.8) 3 (20.0) 24 (24.7) 4 (14.8) 40 (19.1) 13 (29.5)
3rd year 56 (23.0) 28 (25.7) 24 (25.3) 7 (20.6) 7 (41.2) 6 (40.0) 22 (22.7) 9 (33.3) 43 (20.6) 5 (11.4)
4th year 40 (16.4) 20 (18.3) 14 (14.7) 2 (5.9) 3 (17.6) 3 (20.0) 15 (15.5) 5 (18.5) 31 (14.8) 5 (11.4)
5th year 34 (13.9) 11 (10.1) 18 (18.9) 4 (11.8) 0 (0.0) 0 (0.0) 15 (15.5) 3 (11.1) 26 (12.4) 2 (4.5)
State
6
Sindh 154 (48.2) 76 (53.5) 43 (34.4) 19 (44.2) 5 (22.7) 6 (31.6) 71 (52.2) 17 (48.6) 129 (47.1) 26 (46.4)
Punjab 120 (37.6) 45 (31.7) 44 (35.2) 14 (32.6) 13 (59.1) 8 (42.1) 38 (27.9) 9 (25.7) 96 (35.0) 18 (32.1)
KPK and Balochistan 45 (14.1) 21 (14.8) 38 (30.4) 10 (23.2) 4 (18.2) 5 (26.3) 27 (19.9) 8 (22.6) 49 (17.9) 12 (21.4)
Comorbidities
Present 13 (4.1) 6 (4.2) 5 (4.0) 3 (7.0) 2 (9.1) 1 (5.3) 6 (4.4) 2 (5.7) 11 (4.0) 10 (17.9)
Absent 306 (95.9) 136 (95.8) 120 (96.0) 40 (93.0) 20 (90.9) 18 (94.7) 130 (95.6) 33 (94.3) 263 (96.0) 46 (82.1)
Self-reported health
Excellent 63 (19.7) 33 (23.2) 24 (19.2) 11 (25.6) 2 (9.1) 3 (15.8) 24 (17.6) 8 (22.9) 53 (19.3) 7 (12.5)
Good 204 (63.9) 87 (61.3) 79 (63.2) 24 (55.8) 15 (68.2) 10 (52.6) 83 (61.0) 15 (42.9) 176 (64.2) 35 (62.5)
No risk 111 (34.8) 57 (40.1) 44 (35.2) 15 (34.9) 13 (59.1) 11 (57.9) 44 (32.3) 16 (45.7) 92 (33.6) 18 (32.1)
Already infected 63 (19.7) 19 (13.4) 36 (28.8) 7 (16.3) 2 (9.1) 1 (5.3) 22 (16.2) 2 (5.7) 68 (24.8) 11 (19.6)
Mild/Severe 145 (45.4) 66 (46.8) 45 (36.0) 21 (48.8) 7 (31.8) 7 (36.8) 70 (51.5) 17 (48.6) 114 (41.6) 27 (48.2)
Reason
Cold/Flu 263 (82.4) 53 (37.3) 31 (24.8) 10 (23.2) 5 (22.7) 1 (5.3) 53 (39.0) 10 (28.6) 18 (6.6) 27 (48.2)
No symptoms 90 (28.2) 28 (19.7) 16 (12.8) 11 (25.6) 7 (31.8) 1 (5.3) 10 (7.3) 1 (2.8) 81 (29.6) 2 (3.5)
COVID-19 prevention 79 (24.8) 24 (16.9) 21 (16.8) 12 (27.9) 6 (27.2) 2 (10.5) 6 (4.4) 1 (2.8) 71 (25.9) 6 (10.7)
COVID-19 symptoms 104 (32.6) 29 (20.4) 28 (22.4) 7 (16.3) 4 (18.2) 1 (5.3) 7 (5.1) 9 (25.7) 31 (11.3) 13 (23.2)
(Continued)
Frontiers in Public Health | www.frontiersin.org
Yasmin et al.
TABLE 2 | Continued
Factor Parace-tamol Ibuprofen Azithro-mycin HCQ Iver-mectin Doxy- Cetirizine Antiviral Multi-vitamin Other
N = 319 N = 142 N = 125 N = 43 N = 22 cycline N = 136 N = 35 N = 274 N = 56
N = 19
COVID-19 positivity 92 (28.8) 23 (16.2) 38 (30.4) 6 (13.9) 6 (27.3) 2 (10.5) 5 (3.7) 6 (17.1) 60 (21.9) 16 (28.6)
Regular use 97 (30.4) 21 (14.8) 15 (12.0) 5 (11.6) 4 (18.2) 2 (10.5) 19 (14.0) 5 (14.3) 57 (20.8) 19 (33.9)
Others 105 (32.9) 45 (31.7) 17 (13.6) 12 (27.9) 10 (45.4) 3 (15.8) 15 (11.0) 4 (11.4) 16 (5.8) 9 (16.1)
Symptoms
Fever 303 (95.0) 73 (51.4) 32 (25.6) 8 (18.6) 3 (13.6) 2 (10.5) 3 (2.2) 4 (11.4) 12 (4.3) 13 (23.2)
Fatigue 189 (59.2) 43 (30.3) 14 (11.2) 6 (13.9) 4 (18.2) 1 (5.3) 1 (0.7) 2 (5.7) 69 (25.2) 12 (21.4)
Cough 112 (35.1) 30 (21.1) 46 (36.8) 7 (16.3) 3 (13.6) 1 (5.3) 27 (19.8) 3 (8.6) 1 (0.3) 23 (41.1)
Sneezing 96 (30.1) 18 (12.7) 15 (12.0) 8 (18.6) 3 (13.6) 1 (5.3) 73 (53.7) 4 (11.4) 4 (1.5) 14 (25.0)
Muscle pain 196 (61.4) 42 (29.6) 15 (12.0) 9 (20.9) 2 (9.1) 2 (10.5) 4 (2.9) 1 (2.9) 24 (8.8) 11 (19.6)
Nasal congestion 97 (30.4) 26 (18.3) 23 (18.4) 6 (13.9) 1 (4.5) 4 (21.1) 52 (38.2) 2 (5.7) 3 (1.1) 20 (35.7)
Sore throat 98 (30.7) 25 (17.6) 58 (46.4) 5 (11.6) 3 (13.6) 2 (10.5) 19 (14.0) 1 (2.9) 5 (1.8) 21 (37.5)
Anosmia 56 (17.5) 19 (13.4) 17 (13.6) 4 (9.3) 2 (9.1) 0 (0.0) 5 (3.7) 2 (5.7) 11 (4.0) 12 (21.4)
Breathing difficulty 63 (19.7) 21 (14.8) 15 (12.0) 6 (13.9) 4 (18.2) 3 (15.8) 4 (2.9) 3 (8.6) 15 (5.5) 9 (16.1)
No symptoms 110 (34.5) 31 (21.8) 9 (7.2) 9 (20.9) 6 (27.3) 2 (10.5) 8 (5.9) 6 (17.1) 81 (29.6) 6 (10.7)
Alleviated symptoms
All of them 76 (23.8) 30 (21.1) 24 (19.2) 9 (20.9) 2 (9.1) 3 (15.8) 28 (20.6) 8 (22.6) 59 (21.5) 12 (21.4)
Most of them 69 (21.6) 32 (22.5) 29 (23.2) 9 (20.9) 3 (13.6) 4 (21.1) 30 (22.0) 6 (17.1) 56 (20.4) 9 (16.1)
7
Few of them 58 (18.2) 26 (18.3) 19 (15.2) 7 (16.3) 2 (9.1) 4 (21.1) 24 (17.6) 7 (20.0) 54 (19.7) 12 (21.4)
One of them 55 (17.2) 25 (17.6) 25 (20.0) 8 (18.6) 3 (13.6) 3 (15.8) 25 (18.4) 5 (14.3) 50 (18.2) 13 (23.2)
None of them 61 (19.1) 29 (20.4) 28 (22.4) 10 (23.2) 12 (54.5) 5 (26.3) 29 (21.3) 9 (25.7) 55 (20.1) 10 (17.9)
Bold values signify significant p-value (<0.05) by either chi-square or Fisher’s exact test.
Data presented as frequency and percentage.
HCQ, hydroxychloroquine; KPK, Khyber Pakhtunkhwa.
TABLE 3 | Bivariate analysis of the factors associated with the self-medication of various drugs during the COVID-19 lockdown among medical students (n = 489).
Variable Parace-tamol Ibuprofen Azithro-mycin HCQ Iver-mectin Doxy-cycline Cetirizine Antiviral Multi-vitamin Other
Age (years)
18–20 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
21–25 and above 3.554* 1.331 2.766* 0.931 1.432 0.815 1.829* 2.918* 2.025* 1.172
Gender
Female 1.136 1.220 0.723 1.078 1.289 0.321* 0.712 0.343* 2.573* 0.930
Male 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Student
Medical 1.001 1.022 0.965 1.078 1.048 1.159 0.636* 1.041 0.974 1.144
Pharmacy 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Medical year
1st year 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
2nd year 1.669 1.414 1.038 0.631 0.651 1.676 2.286* 1.105 0.909 1.155
3rd year 2.671* 2.063* 1.981* 0.757 2.475 3.543 2.056* 2.709 1.095 0.400
4th year 3.179* 2.210* 1.581 0.299 1.494 2.531 2.046 2.145 1.214 0.605
5th year 4.054* 1.255 3.219* 0.786 – – 2.804* 1.551 1.366 0.284
State
Sindh 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Punjab 1.043 0.696 1.438 0.912 3.569* 1.770 0.617* 0.633 0.935 0.891
KPK/Balochistan 0.970 0.908 5.358* 1.564 2.812 2.962 1.468 1.570 1.953* 1.679
Comorbidities
Present 0.760 0.913 0.850 0.761 2.235 1.188 0.972 1.315 0.776 7.627*
Absent 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Self-reported health
Excellent 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Good 1.795* 1.022 1.365 0.826 2.989 1.294 1.299 0.294* 1.688* 2.143
Fair/Poor 1.559 0.947 1.447 1.055 3.784 3.041 1.611 0.512 1.523 3.524*
COVID risk
No risk 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
Already infected 4.872* 0.935 5.795* 1.366 0.424 0.249 1.604 0.339 12.882* 0.888
Mild/Severe 2.446* 1.357 0.848 1.556 0.561 0.669 2.080* 1.150 1.758* 0.505*
The dependent variable corresponds to the drug used while the reported p-values were obtained by logistic regression model, with the crude odds ratios reported.
P-values <0.05 have a *sign that indicates significant association with the dependent variable. Positive association implies to odds ratio >1.0 and negative association implies to odds
ratio <1.0.
HCQ: hydroxychloroquine; KPK: Khyber Pakhtunkhwa.
was found to be 87% (5) while In Kenya, health care self- Paracetamol was the highest used drug in our study,
medication prevalence was 60.4% among healthcare workers, respondents 21–25 years and above, 5th year medical students,
indicating an increase from pre pandemic results (24). Another those already infected with COVID-19, and stating symptoms
study assessing self-medication prevalence in the Nigerian of cold/flu, fever and fatigue showed significant use. High
population during the pandemic reported a finding of 41% (25). use of Paracetamol aligns with results from the nursing
In Togo, 34.1 % of the participants that belonged to healthcare, undergraduates in Saudi Arabia (17) and from the Peru adult
air transport, police, road transport and informal sectors population (16) where it was also the most consumed drug.
reported to self-medicate and healthcare division had the highest As a widely used first line pharmacotherapy analgesic for
of 51.9% against all sectors (26). Conversely, in Peru, the number tackling pain disorders and different pyrexia, Paracetamol use
of responders not engaging in self-medication was higher than is widely reported in studies comprising of medical students.
those that did, for all drugs including Acetaminophen, Ibuprofen, Health science major students in Nigeria commonly used
Azithromycin, Hydroxychloroquine, Penicillin, Antiretrovirals, it as a pain reliever (25), while medical students in Iran
which were evaluated (16). Multivariate logistic regression model were also frequent users of this drug (27). An Indian study
showed that being female gender, medical school year 3rd, having found medical students to be more likely to self-medicate
been already infected with COVID-19 or having already infected than paramedical students and for this purpose, Paracetamol
with COVID-19 were factors that were associated respondents was consumed mostly (28). Paracetamol has been known to
expected to self-medicate the most. have negligible anti-inflammatory action (28) and guidelines
TABLE 4 | Multivariate analysis of the factors associated with the self-medication practice during the COVID-19 lockdown among medical students (n = 489).
Age (years)
18–20 1.000 - - 1.000 - -
21–25 and above 1.091 0.674–1.767 0.722 1.106 0.656–1.865 0.706
Gender
Female 2.547 1.531–4.239 <0.001* 2.810 1.630–4.843 <0.001*
Male 1.000 - - 1.000 - -
Student
Medical 1.513 0.896–2.556 0.121 1.590 0.914–2.766 0.101
Pharmacy 1.000 - - 1.000 - -
Medical year
1st year 1.000 - - 1.000 - -
2nd year 1.545 0.715–3.337 0.269 1.383 0.588–3.254 0.457
3rd year 3.003 1.175–7.677 0.022* 3.591 1.127–11.444 0.031*
4th year 1.655 0.669–4.093 0.276 1.517 0.435–5.289 0.513
5th year 1.094 0.453–2.644 0.842 1.034 0.278–3.849 0.960
State
Sindh 1.000 - - 1.000 - -
Punjab 0.796 0.485–1.306 0.366 0.685 0.402–1.168 0.164
KPK and Balochistan 2.166 0.878–5.344 0.094 1.862 0.737–4.705 0.189
Comorbidities
Present 0.526 0.200–1.388 0.195 0.567 0.202–1.590 0.281
Absent 1.000 - - 1.000 - -
Self-reported health
Excellent 1.000 - - 1.000 - -
Good 1.826 1.065–3.132 0.029* 1.853 1.053–3.261 0.032*
Fair/Poor 1.576 0.756–3.286 0.225 1.530 0.710–3.299 0.278
COVID risk
No risk 1.000 - - 1.000 - -
Already infected 2.230 0.999–4.980 0.050* 1.904 0.832–4.356 0.127
Mild/Severe 1.509 0.907–2.509 0.113 1.304 0.765–2.223 0.329
issued during the initial months of the pandemic state that Multivitamins were the second highest consumed drug in our
it can be used for treating mild COVID-19 symptoms when study, which have also been the drug of choice as divulged in
managing patients at home (29) or for self-medication, especially a population-based survey during COVID-19 in Nigeria with
for fever or headache (30). This is consistent with our 51.8% reporting to use this group of medicine (25). In Togo,
results corresponding to Paracetamol use as it was greatly 27.6% used Vitamin C when self-medicating (26), while in Egypt,
used to treat “fever” in our study population, and its use 27% used vitamin C and 17.7% used vitamin D (31). A study
also showed improvement in all or most of the symptoms from 2015 involving healthcare and non-healthcare university
experienced by the responders who employed Paracetamol. students from South India found multivitamins to be among
However, some instances report the drug to be exacerbating the most commonly self-medicated drugs (32). Multivitamins
COVID-19 symptoms, likely due to activation of prothrombotic include multiple vitamins and minerals, trace elements all of
mechanisms which is known as one of the leading pathogenic which possess antioxidant properties and have a crucial role in
causes of COVID-19 (29). Single or repeated high Paracetamol regulating immune function and can reduce risk of respiratory
dose, or chronic ingestion above therapeutic doses can result infection (33). A large observational study conducted in US,
in hepatotoxicity (17). Hepatotoxicity from intentional or non- UK, and Sweden during first waves of COVID-19 demonstrated
intentional Paracetamol overdose is the most common cause a modest protective effect among those taking multivitamin
of drug-induced liver injury and is a global issue (17). The supplements with a reduced risk for testing positive for SARS-
medicine’s toxic dosage effects must be known to students CoV-2 (33). Hence, these might explain the significant use of
utilizing it. multivitamins by females and participants 21–25 years and above.
Additionally, individuals with COVID-19 can experience weight fear and stigma, knowledge and access to prescription-only
loss; having adequate amounts of vitamins and minerals can medicines while trying to keep one’s health status, especially
prevent this unintended reduction in weight (34). Moreover, if infected with COVID-19, could be accounted for self-
a deficiency in certain micronutrients such as Vitamin A, medication rates among the medical students’ community (26).
Vitamin D, Zinc can be deleterious during viral infections (33). Furthermore, practicing self-medication allowed the students
These factors might elucidate why those infected with COVID- to exercise freedom in managing their health and wellbeing
19 in our research resorted to a significantly high rate of instilling a sense of independence (24). The overall high self-
multivitamin use. medication rate throughout all year groups can be ascribed to
Ibuprofen was the third highest self-medicated drug in the extensive educational load upon these students and stressful
our population. Previously, it has been reported to be the circumstances which results in distress and compels them to
most preferred NSAID for analgesic purposes among nursing seek OTC drugs (45). Another study conducted in Poland
undergraduates in Saudi Arabia (20%) (17). As a non- highlighted such behaviors increased during lockdown (46).
steroidal anti-inflammatory drug (NSAID), it is well tolerated According to a study from Jordan, factors such as female gender,
and effective during pain and inflammation and has minor working in the medical field, and history of COVID-19 infection
side effects (17). Alongside Paracetamol, it is one of the were reportedly associated with self-medication similar to our
most extensively used antipyretic (35). Since the start of findings (47).
the pandemic, Ibuprofen use has been subject to debate While the high self-medication percentage suggests medical
(36). Initially discouraged for use as it was suspected to students’ confidence while self-prescribing, the possibility
aggravate infections (37), such claims were later rejected. A that students’ knowledge about drug pharmacology, cultural
study analyzing data from ISARIC Clinical Characterization prevalence, and limited experience at the current student level
Protocol UK cohort found NSAIDS use not disposing to can make them susceptible to unfavorable outcomes, must not
any poor COVID-19 outcome (38). A 2021 systematic review be undermined (28). Drug addiction and drug dependence
and meta-analysis reiterated similar findings and revealed (29) can also be induced by repeated self-medication, which
no negative association between use of NSAIDS, including students must be aware of. Lockdown and isolation guidelines
Ibuprofen, with SARS-CoV-2 infection or its outcomes (39). have prevented the population from visiting hospitals and
Ibuprofen has been known to have a better analgesic response clinics and have altered health-seeking behavior. As different
in men while higher threshold and greater tolerance for SARS-CoV-2 variants keep emerging, people are likely to self-
electrically induced pain, responded significantly to ibuprofen medicate (48). Medical students are also probable to keep self-
in contrast to women (40). Nevertheless, the high use of medicating, which could be helpful in obtaining benefits of
this drug during COVID-19 can be linked to its efficacy in self-care, and alleviating burden on the healthcare system of
relieving fever, infection (35). However, users must be wary that the country by reducing number of physician visits (49). By
disproportionate use of the drug can cause adverse drug reactions practicing self-medication wisely themselves, staying mindful of
(ADRs) (17). the pharmacological and taxological risks of improper drug use
Hydroxychloroquine and ivermectin, the sales of which (25), they could facilitate the lay population to treat themselves
escalated globally in wake of COVID-19 were found to be for minor ailments which could further relieve pressure on health
consumed in low amounts in our study (41). Other frequently care setups.
used drugs were Cetirizine and Azithromycin. Azithromycin has The study is important as questions specific to the drug
been popular amongst antibiotics that have been used for self- trends in the local population were incorporated, and responses
medication in Pakistan (21) and has also been an alternative for from all parts of the country were received. However, as
self-medication in other countries such as Saudi Arabia (17) and online platforms were used for disseminating the questionnaire,
Peru (16). Using antibiotics during self-medication is the leading students in remote areas with no access to the internet
cause of antimicrobial resistance (42) thus its intake must be could not be a part of the survey. Other limitation included
regulated, its appropriate use and disposal ensured especially by non-random sampling method and generalizability of study
medical students. results. Besides, due to recall bias, some responders might have
The most common reason for use of the respective drug answered incorrectly.
was “cold/flu”, consistent with results from studies of including
medical students from Iran (29, 43) and Brazil (44). “Fever”,
one of the most common COVID-19 symptom (19), followed CONCLUSION
by “Muscle Pain” were the highest symptomologies reported
for medicine use. Analgesic use for muscular pain at any site Our study revealed common self-medication practices among
was also highly common among undergraduate medical and medical and pharmacy students. It is a significant health issue
paramedical students in India (28). Studies evaluating medical especially during the pandemic times, with high consumption
students’ attitudes toward self-medication delineate sufficient reported as a prevention or treating symptoms of COVID-
knowledge, familiarity with disease, and time constraints which 19. Further measures are needed to improve healthcare
can also be cited as motives for self-medication among our policies regarding awareness and sensitization about the
participants in this pandemic scenario (17). In the early days risks of self-medication. Future studies should also assess
of SARS-CoV-2 outbreak, when the disease was a source of students’ attitude toward self-medication, their knowledge
regarding drug dosage and potential side effects, and the AUTHOR CONTRIBUTIONS
role of medical colleges to better ascertain their approach
toward self-medication. FY: conceptualization. UN, HNaj, HNau, and AK: data curation.
MSA: formal analysis. FY and MNA: funding acquisition. FY, UN,
and HNaj: investigation. MSA and AK: methodology. FY, UN,
DATA AVAILABILITY STATEMENT
and AK: project administration. UN, HNaj, and HNau: resources.
The raw data supporting the conclusions of this article will be MSA and HNau: software. MSA, HNau, and AK: validation.
made available by the authors, without undue reservation. HNaj and HNau: visualization. UN and HNau: writing—original
draft. FY, MSA, MNA, and AK: writing—review and editing. All
authors approved the final version of the manuscript.
ETHICS STATEMENT
The studies involving human participants were reviewed and SUPPLEMENTARY MATERIAL
approved by Ethics Approval was taken in this study from
Institutional Review Board of Dow University Ojha Hospital The Supplementary Material for this article can be found
(Approval No. IRB (DUH)-2020/174/021), and content to online at: https://www.frontiersin.org/articles/10.3389/fpubh.
participate was obtained from all the individuals through 2022.803937/full#supplementary-material
online platform. The patients/participants provided their written Supplementary Figure 1 | Crude and Adjusted level analysis of factors
informed consent to participate in this study. associated with self-medication among medical students.
25. Wegbom AI, Edet CK, Raimi O, Fagbamigbe AF, Kiri VA. Self-medication 39. Moore N, Bosco-Levy P, Thurin N, Blin P, Droz-Perroteau C. NSAIDs and
practices and associated factors in the prevention and/or treatment of COVID-19: a systematic review and meta-analysis. Drug Saf. (2021) 44:929–
COVID-19 virus: a population-based survey in Nigeria. Front Public Heal. 38. doi: 10.1007/s40264-021-01089-5
(2021) 9:606801. doi: 10.3389/fpubh.2021.606801 40. Farkouh A, Baumgärtel C, Gottardi R, Hemetsberger M, Czejka M, Kautzky-
26. Sadio AJ, Gbeasor-Komlanvi FA, Konu RY, Bakoubayi AW, Tchankoni MK, Willer A. Sex-related differences in drugs with anti-inflammatory properties.
Bitty-Anderson AM, et al. Assessment of self-medication practices in the J Clin Med. (2021) 10:1441. doi: 10.3390/jcm10071441
context of the COVID-19 outbreak in Togo. BMC Public Health. (2021) 41. Hashmi FK, Atif N, Malik UR, Riboua Z, Saleem F, Khan YH, et al.
21:58. doi: 10.1186/s12889-020-10145-1 Misinformation in wake of the COVID-19 outbreak: fueling shortage and
27. Abdi A, Faraji A, Dehghan F, Khatony A. Prevalence of self- misuse of lifesaving drugs in Pakistan. Disaster Med Public Health Prep. (2021)
medication practice among health sciences students in Kermanshah, 15:e32–3. doi: 10.1017/dmp.2020.400
Iran. BMC Pharmacol Toxicol. (2018) 19:36. doi: 10.1186/s40360-018- 42. Rather IA, Kim B-C, Bajpai VK, Park Y-H. Self-medication and antibiotic
0231-4 resistance: crisis, current challenges, and prevention. Saudi J Biol Sci. (2017)
28. Chindhalore CA, Dakhale GN, Giradkar AB. Comparison of self- 24:808–12. doi: 10.1016/j.sjbs.2017.01.004
medication practices with analgesics among undergraduate medical and 43. Hashemzaei M, Afshari M, Koohkan Z, Bazi A, Rezaee R, Tabrizian
paramedical students of a tertiary care teaching institute in Central K. Knowledge, attitude, and practice of pharmacy and medical students
India – a questionnaire-based study. J Educ Health Promot. (2020) regarding self-medication, a study in Zabol University of Medical Sciences;
9:309. doi: 10.4103/jehp.jehp_378_20 Sistan and Baluchestan province in south-east of Iran. BMC Med Educ. (2021)
29. Pandolfi S, Simonetti V, Ricevuti G, Chirumbolo S. Paracetamol in the home 21:49. doi: 10.1186/s12909-020-02374-0
treatment of early COVID-19 symptoms: a possible foe rather than a friend 44. Corrêa Da Silva MG, Soares MCF, Muccillo-Baisch AL. Self-medication in
for elderly patients? J Med Virol. (2021) 93:5704–6. doi: 10.1002/jmv.27158 university students from the city of Rio Grande, Brazil. BMC Public Health.
30. Paracetamol or ibuprofen can be used to treat the symptoms of COVID-19, (2012) 12:339. doi: 10.1186/1471-2458-12-339
says NHS England. Pharm J. Available online at: https://pharmaceutical- 45. Bekele KM, Abay AM, Mengistu KA, Atsbeha BW, Demeke CA, Belay WS,
journal.com/article/news/paracetamol-or-ibuprofen-can-be-used-to-treat- et al. Knowledge, attitude, and practice on over-the-counter drugs among
the-symptoms-of-covid-19-says-nhs-england (accessed April 20, 2020). pharmacy and medical students: a facility-based cross-sectional study. Integr
31. Khabour OF, Hassanein SFM. Use of vitamin/zinc supplements, Pharm Res Pract. (2020) 9:135–46. doi: 10.2147/IPRP.S266786
medicinal plants, and immune boosting drinks during COVID-19 46. Makowska M, Boguszewki R, Nowakowski M, Podkowińska M. Self-
pandemic: a pilot study from Benha city, Egypt. Heliyon. (2021) medication-related behaviors and Poland’s COVID-19 lockdown. Int J
7:e06538. doi: 10.1016/j.heliyon.2021.e06538 Environ Res Public Health. (2020) 17:8344. doi: 10.3390/ijerph17228344
32. Sharma A, Oommen S, Topno I, Saya RP. Perceptions and practices 47. Elayeh E, Akour A, Haddadin RN. Prevalence and predictors of self-
of self-medication in healthcare and nonhealthcare university medication drugs to prevent or treat COVID-19: experience from a Middle
students in South India. J Basic Clin Physiol Pharmacol. (2015) Eastern country. Int J Clin Pract. (2021) 75:e14860. doi: 10.1111/ijcp.14860
26:633–40. doi: 10.1515/jbcpp-2015-0025 48. Rafiq K, Nesar S, Anser H, Leghari QA, Hassan A, Rizvi A, et al. Self-
33. Louca P, Murray B, Klaser K, Graham MS, Mazidi M, Leeming ER, et medication in the COVID-19 pandemic: survival of the fittest. Disaster Med
al. Modest effects of dietary supplements during the COVID-19 pandemic: Public Health Prep. (2021) 8:1–5. doi: 10.1017/dmp.2021.173
insights from 445 850 users of the COVID-19 Symptom Study app. BMJ Nutr 49. Noone J, Blanchette CM. The value of self-medication: summary of existing
Prev Heal. (2021) 4:149–57. doi: 10.1136/bmjnph-2021-000250 evidence. J Med Econ. (2018) 21:201–11. doi: 10.1080/13696998.2017.1390473
34. Harvard TH. Chan School of Public Health. Ask the Expert: The Role of Diet
and Nutritional Supplements During COVID-19 | The Nutrition Source. 2020. Conflict of Interest: The authors declare that the research was conducted in the
Available online at: https://www.hsph.harvard.edu/nutritionsource/2020/04/ absence of any commercial or financial relationships that could be construed as a
01/ask-the-expert-the-role-of-diet-and-nutritional-supplements-during- potential conflict of interest.
covid-19/ (accessed August 24, 2021).
35. Esba LCA, Alqahtani RA, Thomas A, Shamas N, Alswaidan L, Mardawi G. Publisher’s Note: All claims expressed in this article are solely those of the authors
Ibuprofen and NSAID use in COVID-19 infected patients is not associated and do not necessarily represent those of their affiliated organizations, or those of
with worse outcomes: a prospective cohort study. Infect Dis Ther. (2021)
the publisher, the editors and the reviewers. Any product that may be evaluated in
10:253–68. doi: 10.1007/s40121-020-00363-w
this article, or claim that may be made by its manufacturer, is not guaranteed or
36. Carius BM, Schauer SG. Ibuprofen during the COVID-19 pandemic: social
media precautions and implications. West J Emerg Med. (2020) 21:497– endorsed by the publisher.
8. doi: 10.5811/westjem.2020.4.47686
37. Rinott E, Kozer E, Shapira Y, Bar-Haim A, Youngster I. Copyright © 2022 Yasmin, Asghar, Naeem, Najeeb, Nauman, Ahsan and Khattak.
Ibuprofen use and clinical outcomes in COVID-19 patients. This is an open-access article distributed under the terms of the Creative Commons
Clin Microbiol Infect. (2020) 26:1259. doi: 10.1016/j.cmi.2020. Attribution License (CC BY). The use, distribution or reproduction in other forums
06.003 is permitted, provided the original author(s) and the copyright owner(s) are credited
38. Kragholm K, Torp-Pedersen C, Fosbol E. Non-steroidal anti- and that the original publication in this journal is cited, in accordance with accepted
inflammatory drug use in COVID-19. Lancet Rheumatol. (2021) 3:e465–6. academic practice. No use, distribution or reproduction is permitted which does not
doi: 10.1016/S2665-9913 (21)00144-2 comply with these terms.